🚀 VC round data is live in beta, check it out!
Veeva Valuation Multiples
Discover revenue and EBITDA valuation multiples for Veeva and similar public comparables like IQVIA, GE HealthCare, Roper Technologies, United Imaging and more.
Veeva Overview
About Veeva
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Founded
2007
HQ
Employees
7.3K
Website
Financials (LTM)
EV
$21B
Veeva Financials
Veeva reported last 12-month revenue of $3B and EBITDA of $1B.
In the same LTM period, Veeva generated $3B in gross profit, $1B in EBITDA, and $1B in net income.
Revenue (LTM)
Veeva P&L
In the most recent fiscal year, Veeva reported revenue of $3B and EBITDA of $1B.
Veeva expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 76% | XXX | XXX | XXX |
| EBITDA | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA Margin | 45% | XXX | 45% | XXX | XXX | XXX |
| EBIT Margin | 45% | XXX | 45% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Net Margin | 42% | XXX | 42% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Veeva Stock Performance
Veeva has current market cap of $27B, and enterprise value of $21B.
Market Cap Evolution
Veeva's stock price is $167.95.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $21B | $27B | 0.0% | XXX | XXX | XXX | $8.28 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVeeva Valuation Multiples
Veeva trades at 6.4x EV/Revenue multiple, and 14.1x EV/EBITDA.
EV / Revenue (LTM)
Veeva Financial Valuation Multiples
As of April 19, 2026, Veeva has market cap of $27B and EV of $21B.
Equity research analysts estimate Veeva's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Veeva has a P/E ratio of 19.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $27B | XXX | $27B | XXX | XXX | XXX |
| EV (current) | $21B | XXX | $21B | XXX | XXX | XXX |
| EV/Revenue | 6.4x | XXX | 6.6x | XXX | XXX | XXX |
| EV/EBITDA | 14.1x | XXX | 14.4x | XXX | XXX | XXX |
| EV/EBIT | 14.3x | XXX | 14.6x | XXX | XXX | XXX |
| EV/Gross Profit | 8.3x | XXX | 8.7x | XXX | XXX | XXX |
| P/E | 19.9x | XXX | 20.3x | XXX | XXX | XXX |
| EV/FCF | 14.7x | XXX | 14.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Veeva Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Veeva Margins & Growth Rates
Veeva's revenue in the last 12 month grew by 13%.
Veeva's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Veeva's rule of 40 is 57% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Veeva's rule of X is 76% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Veeva Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 45% | XXX | 45% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 11% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 57% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 76% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 11% | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 9% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 19% | XXX | 24% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Veeva Public Comps
See public comps and valuation multiples for other Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Veeva | XXX | XXX | XXX | XXX | XXX | XXX |
| IQVIA | XXX | XXX | XXX | XXX | XXX | XXX |
| GE HealthCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Roper Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| United Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| Pro Medicus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Veeva M&A Activity
Veeva acquired XXX companies to date.
Last acquisition by Veeva was on XXXXXXXX, XXXXX. Veeva acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Veeva
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVeeva Investment Activity
Veeva invested in XXX companies to date.
Veeva made its latest investment on XXXXXXXX, XXXXX. Veeva invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Veeva
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Veeva
| When was Veeva founded? | Veeva was founded in 2007. |
| Where is Veeva headquartered? | Veeva is headquartered in United States. |
| How many employees does Veeva have? | As of today, Veeva has over 7K employees. |
| Who is the CEO of Veeva? | Veeva's CEO is Peter P. Gassner. |
| Is Veeva publicly listed? | Yes, Veeva is a public company listed on NYSE. |
| What is the stock symbol of Veeva? | Veeva trades under VEEV ticker. |
| When did Veeva go public? | Veeva went public in 2013. |
| Who are competitors of Veeva? | Veeva main competitors are IQVIA, GE HealthCare, Roper Technologies, United Imaging. |
| What is the current market cap of Veeva? | Veeva's current market cap is $27B. |
| What is the current revenue of Veeva? | Veeva's last 12 months revenue is $3B. |
| What is the current revenue growth of Veeva? | Veeva revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Veeva? | Current revenue multiple of Veeva is 6.4x. |
| Is Veeva profitable? | Yes, Veeva is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Veeva? | Veeva's last 12 months EBITDA is $1B. |
| What is Veeva's EBITDA margin? | Veeva's last 12 months EBITDA margin is 45%. |
| What is the current EV/EBITDA multiple of Veeva? | Current EBITDA multiple of Veeva is 14.1x. |
| What is the current FCF of Veeva? | Veeva's last 12 months FCF is $1B. |
| What is Veeva's FCF margin? | Veeva's last 12 months FCF margin is 44%. |
| What is the current EV/FCF multiple of Veeva? | Current FCF multiple of Veeva is 14.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.